The purpose of this FOA is to encourage investigators to work together on innovative approaches to eliminate HIV-1 and leverage the expertise and resources of the participating Institutes. Research topics of interest are as follows: cell therapies, including those based on hematopoietic stem cells; novel gene therapy approaches; and the development and delivery of non-traditional antiviral strategies (e.g. miRNAs, siRNAs, gene-editing enzymes). Applications are expected to include basic science/preclinical research as well as translational activities such as test-of-concept studies in animal models or humans.
1- Declaration of interest: IISPV’s deadline: April 28, 2014 (email@example.com)
2- NIH Register; create PI account(s); affiliate PI account to IISPV, etc.
3- LOI: June 21, 2014
4- Full proposal: IISPV’s deadline: Application July 19, 2014
Open Date (Earliest Submission Date): June 28, 2014
Letter of Intent Due Date(s): June 28, 2014
Application Due Date(s): July 28, 2014, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s): July 28, 2014 by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Omple el següent formulari per rebre més informació:
En el moment actual que ens toca viure, la pandèmia desencadenada pel nou virus SARS- Cov2 (Covid-19) ens ha portat a trobar noves formes per afrontar la malaltia, des de la recerca en nous tractaments fins mirar de prevenir els contagis i els nous brots, són tasques en les que podem i hem d’ajudar des dels Instituts de recerca en salut.Col·labora